KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Inventory Average (2016 - 2025)

Historic Inventory Average for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $28.5 million.

  • Neogenomics' Inventory Average rose 1136.8% to $28.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.5 million, marking a year-over-year increase of 1136.8%. This contributed to the annual value of $27.7 million for FY2025, which is 866.34% up from last year.
  • Per Neogenomics' latest filing, its Inventory Average stood at $28.5 million for Q4 2025, which was up 1136.8% from $31.3 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Inventory Average peaked at $32.0 million during Q2 2025, and registered a low of $21.4 million during Q2 2021.
  • Over the past 5 years, Neogenomics' median Inventory Average value was $24.1 million (recorded in 2022), while the average stood at $24.8 million.
  • As far as peak fluctuations go, Neogenomics' Inventory Average crashed by 1183.34% in 2024, and later surged by 4688.06% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Inventory Average stood at $22.6 million in 2021, then grew by 6.29% to $24.0 million in 2022, then rose by 0.28% to $24.1 million in 2023, then increased by 6.21% to $25.6 million in 2024, then increased by 11.37% to $28.5 million in 2025.
  • Its last three reported values are $28.5 million in Q4 2025, $31.3 million for Q3 2025, and $32.0 million during Q2 2025.